Due diligence is being carried out on the majority stake in Polish imaging to IT services group Voxel, Healthcare Euopa can reveal. Meanwhile, the company, which is quoted on the Warsaw Stock Exchange, has just announced stonking figures for 2015.
We talked to Charles Woler, who turned around French reference lab Biomnis and is now the CEO of bioDS - Biomnis holding company, part of Eurofins. He sees signs that governments are starting to think the unthinkable and that public sector outsourcing of lab tests could grow. Woler is also a panelist at our annual conference, Breaking Barriers 2016 conference.
Having IPOed as recently as June 2015, Finnish healthcare group Pihlajalinna is to ask shareholders for a mandate to issue an extra €40m in shares. The shares have soared 70% above the IPO price to over €17. A €40m issue would leave the company with €70m of net cash. What might the company buy and what does the move tell us about the Finnish market?
Big pharma is trying and failing to engage with patients and has no idea how to build service models. Previous attempts to create websites that directly engage with consumers have flopped. The appallingly-named “patient-centricity” sessions at the FT Global Pharmaceutical and Biotechnology Conference suggest pharma is still trying in vain.
Mexico boasts a large, innovative and vibrant private healthcare sector, which sits alongside a developing, but somewhat chaotic public sector. We look at the major players in the private sector, as well as at new innovators seeking to cut the cost of treatment to reach the masses.
Private operators and their backers are racing to build large chains of outpatient clinics across Mexico. They hope that the right-wing government will allow new much longer term public-private partnerships. Meanwhile, the bodies which make up the Mexican NHS and the payor for services for the poor are in their worst financial situation in history. The minister of health has suggested that they may need to be merged to create a new universal health insurance plan.
This week I thought I’d lay out the rationale behind our annual conference, now in its sixth year, which now covers private health care across Europe and all Emerging markets....
Healthcare Europa mistakenly reported last week that InterHealth Canada has been appointed to run the PPP in Grodno, Belarus. We have now been told by Interhealth that this is not the case. There is no information on which company was awarded the contract at this stage.
Given the size of the opportunity it is striking how little money is being invested by large financial institutions, private equity houses and big quoted groups in Emerging Markets. Why? And what is the way forward?
Pihlajalinna, the Finnish healthcare and social services outfit, which recently IPOed with a market capitalisation of €255m, has struck a third joint venture with Finnish municipalities to outsource health and social services. Finland is likely to open up even more to the private sector under the current government.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.